Mesoblast Limited Level 39 55 Collins Street Melbourne 3000 AUSTRALIA +61 3 9639 6036 Email:info@mesoblast.com
For media and shareholder inquiries: Julie Meldrum Corporate Communications Director E: julie.meldrum@mesoblast.com + 61 (0) 419 228 128
22 January - RBS Equities Research: Mesoblast - Analysis of MSB’s Opportunities
8 January - Southern Cross Equities Research: Mesoblast – The Stem Cell Opportunity
December 22 - RBS Equities Research: Diabetes - An Expanding Portfolio
December 21 - Mesoblast - National Electronic Media Coverage
30 March 2009 - RBS Equities Research
17 March 2009 - Lodge Partners Research Report
27 February 2009 - ABN AMRO Equity Research
July 2009 - Chairman’s Letter
May 2009 - Chairman’s Letter
May 2008 - Issue Nine
© Copyright Mesoblast Limited 2010. All rights reserved. Website design by Infoprobe Australia
disclaimer | privacy policy
home | contact | sitemap | Angioblast Systems | webmail the company | the technology | product development | investor centre | news room
